CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 23 filers reported holding CITIUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,554 | +1.5% | 72,406 | +77.9% | 0.00% | – |
| Q2 2023 | $48,843 | +5.3% | 40,703 | +2.7% | 0.00% | – |
| Q1 2023 | $46,390 | +28.3% | 39,650 | -13.1% | 0.00% | – |
| Q4 2022 | $36,160 | -17.8% | 45,650 | +24.6% | 0.00% | – |
| Q3 2022 | $44,000 | +37.5% | 36,650 | +5.8% | 0.00% | – |
| Q2 2022 | $32,000 | -48.4% | 34,650 | 0.0% | 0.00% | – |
| Q1 2022 | $62,000 | +17.0% | 34,650 | 0.0% | 0.00% | – |
| Q4 2021 | $53,000 | -30.3% | 34,650 | -8.0% | 0.00% | – |
| Q3 2021 | $76,000 | -46.1% | 37,650 | -7.0% | 0.00% | – |
| Q2 2021 | $141,000 | +7.6% | 40,500 | -45.3% | 0.00% | – |
| Q1 2021 | $131,000 | +142.6% | 74,000 | +41.0% | 0.00% | – |
| Q4 2020 | $54,000 | +980.0% | 52,500 | +950.0% | 0.00% | – |
| Q3 2020 | $5,000 | +400.0% | 5,000 | +400.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 196,867 | $181,000 | 0.05% |
| Wealth Advisory Solutions, LLC | 156,850 | $144,000 | 0.04% |
| Horst & Graben Wealth Management LLC | 75,722 | $70,000 | 0.02% |
| Ergoteles LLC | 451,890 | $416,000 | 0.01% |
| Miller Investment Management, LP | 50,000 | $46,000 | 0.01% |
| Virtu Financial LLC | 81,410 | $75,000 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 17,342 | $16,000 | 0.00% |
| Kestra Advisory Services, LLC | 71,102 | $65,000 | 0.00% |
| Csenge Advisory Group | 15,000 | $14,000 | 0.00% |
| Qube Research & Technologies Ltd | 121,281 | $112,000 | 0.00% |